Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

71 Results Found

Congress urges FDA action to address drug shortages

A bipartisan group of 92 members of Congress yesterday urged the Food and Drug Administration to prioritize the release of an interagency task force report on the root causes of drug shortages and recommendations to address them.

Survey: Drug shortages cost hospitals $360M annually

Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.

CREATES Act, other bills to boost generic competition advance in House

The House Judiciary Committee yesterday approved by voice vote the Creating and Restoring Equal Access to Equivalent Samples Act (H.R. 965).

Civica Rx opens Utah headquarters

Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.

Hospitals, health systems launch not-for-profit generic drug company

Several hospitals and health systems today officially established Civica Rx – a new not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications.
Public

AHA’s Feedback on the Public Meeting, “Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions

AHA provides feedback on the Food and Drug Administration’s request for comments on the public meeting, “Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions.
Public

AHA Comments on HHS' Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.

AHA comments on DEA’s proposed rule on controlled substances quotas

We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of controlled substances in amounts exceeding legitimate

Group letter re: DEA’s proposed rule on controlled substances quotas

The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled substances quotas.

AHA recommends legislative, regulatory actions to address drug shortages

The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription drug shortages that threaten the quality of patient care and increase hospital and health system costs.